Cargando…

Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity

Mitogen-activated protein kinase (MAPK) pathways represent ubiquitous signal transduction pathways that regulate all aspects of life and are frequently altered in disease. Here, we focus on the role of MAPK pathways in modulating drug sensitivity and resistance in cancer. We briefly discuss new find...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Shannon, Rauch, Jens, Kolch, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037308/ https://www.ncbi.nlm.nih.gov/pubmed/32046099 http://dx.doi.org/10.3390/ijms21031102

Ejemplares similares

A systematic analysis of signaling reactivation and drug resistance
por: Kholodenko, Boris N., et al.
Publicado: (2021)

When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling
por: Nguyen, Lan K, et al.
Publicado: (2013)

Cell Type-Specific Activation of AKT and ERK Signaling Pathways by Small Negatively-Charged Magnetic Nanoparticles
por: Rauch, Jens, et al.
Publicado: (2012)

The secret life of kinases: functions beyond catalysis
por: Rauch, Jens, et al.
Publicado: (2011)

Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling
por: Nolan, Aoife A., et al.
Publicado: (2021)

Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development
por: Shilo, Asaf, et al.
Publicado: (2014)

miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway
por: van Jaarsveld, Marijn T. M., et al.
Publicado: (2015)

Targeting KRAS in Pancreatic Cancer
por: Cowzer, Darren, et al.
Publicado: (2022)

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
por: Yuan, Jimin, et al.
Publicado: (2020)

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
por: Uribe, Mary Luz, et al.
Publicado: (2021)

Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers
por: Dillon, Martha, et al.
Publicado: (2021)

RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy
por: García-Gutiérrez, Lucía, et al.
Publicado: (2020)

Mechanisms of resistance to EGFR-targeted drugs: lung cancer
por: Morgillo, Floriana, et al.
Publicado: (2016)

Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
por: Kinnel, Briana, et al.
Publicado: (2023)

Targeting MAPK Signaling in Age-Related Macular Degeneration
por: Kyosseva, Svetlana V.
Publicado: (2016)

Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
por: Alatise, Kharimat Lora, et al.
Publicado: (2022)

Interactome dynamics of RAF1-BRAF kinase monomers and dimers
por: Iglesias-Martinez, Luis F., et al.
Publicado: (2023)

Drug resistance mechanisms of cancer stem-like cells and their therapeutic potential as drug targets
por: Murayama, Takahiko, et al.
Publicado: (2019)

Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
por: Wu, Jiajia, et al.
Publicado: (2022)

Signalling mechanisms regulating phenotypic changes in breast cancer cells
por: Volinsky, Natalia, et al.
Publicado: (2015)

Understanding Drug Sensitivity and Tackling Resistance in Cancer
por: Tyner, Jeffrey W., et al.
Publicado: (2022)

Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways
por: Sevilla, Lisa M., et al.
Publicado: (2021)

Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems
por: Lainetti, Patrícia de Faria, et al.
Publicado: (2020)

Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
por: Al Bitar, Samar, et al.
Publicado: (2023)

Evolution of resistance to MAPK-targeted therapies
por: Lo, Roger
Publicado: (2015)

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma
por: Krayem, Mohamad, et al.
Publicado: (2020)

Pseudophosphatases as Regulators of MAPK Signaling
por: Hepworth, Emma Marie Wilber, et al.
Publicado: (2021)

LGG-02. DRUG-CLASS SPECIFIC GENE-BASED MAPK SENSITIVITY SCORES (MSS) PREDICT SENSITIVITY TO MAPK INHIBITORS AND IDENTIFY IMMUNE INFILTRATION AS PUTATIVE TARGET IN PEDIATRIC LOW-GRADE GLIOMAS
por: Sigaud, Romain, et al.
Publicado: (2023)

All over the place: deciphering HRAS signaling from different subcellular compartments
por: Kolch, Walter, et al.
Publicado: (2019)

Evaluating Strategies to Normalise Biological Replicates of Western Blot Data
por: Degasperi, Andrea, et al.
Publicado: (2014)

Dynamic regulation of RAS and RAS signaling
por: Kolch, Walter, et al.
Publicado: (2023)

Emergence of bimodal cell population responses from the interplay between analog single-cell signaling and protein expression noise
por: Birtwistle, Marc R, et al.
Publicado: (2012)

PAK Signaling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-mutant Melanomas
por: Lu, Hezhe, et al.
Publicado: (2017)

Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance
por: Fröhlich, Fabian, et al.
Publicado: (2023)

Wnt/β-catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer
por: Zhu, Gui-Xian, et al.
Publicado: (2021)

Emerging RAS-directed therapies for cancer
por: Conroy, Michael, et al.
Publicado: (2021)

Precision drugging of the MAPK pathway in head and neck cancer
por: Ngan, Hoi-Lam, et al.
Publicado: (2022)

Emerging targets in cancer drug resistance
por: Kumar, Shashank, et al.
Publicado: (2019)

Overcoming Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutated Tumours
por: Paton, Emily L., et al.
Publicado: (2020)

Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL
por: Zhang, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p1ibgp3qff6kgmcmbas9d7uh8t